Ioannis Kioumis

Summary

Affiliation: University of Athens
Country: Greece

Publications

  1. doi request reprint Validation of the Infectious Diseases Society of America/American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniae
    Paschalina Kontou
    Division of Pulmonary Critical Care, G Papanikolaou Hospital, Thessaloniki, Greece
    Am J Emerg Med 27:968-74. 2009
  2. pmc Pharmacokinetics of ciprofloxacin and its penetration into bronchial secretions of mechanically ventilated patients with chronic obstructive pulmonary disease
    Paschalina Kontou
    A Intensive Care Unit, G Papanikolaou Hospital, Exohi, Thessaloniki 57010, Greece
    Antimicrob Agents Chemother 55:4149-53. 2011
  3. pmc Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment
    Georgia Pitsiou
    Pulmonary Department, G Papanikolaou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
    Drug Des Devel Ther 8:1753-63. 2014
  4. pmc Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol
    Paul Zarogoulidis
    Pulmonary Department Oncology Unit, G Papanikolaou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
    Drug Des Devel Ther 8:1065-72. 2014
  5. doi request reprint Pharmacokinetics of moxifloxacin and high-dose levofloxacin in severe lower respiratory tract infections
    Paschalina Kontou
    A Intensive Care Unit, G Papanikolaou Hospital, Thessaloniki, Greece
    Int J Antimicrob Agents 42:262-7. 2013
  6. pmc Moxifloxacin pharmacokinetics and pleural fluid penetration in patients with pleural effusion
    Kalliopi Chatzika
    Respiratory Infections Unit, Pulmonary Department, Aristotle University of Thessaloniki, G Papanikolaou Hospital, Thessaloniki, Greece
    Antimicrob Agents Chemother 58:1315-9. 2014
  7. doi request reprint Sarcoidosis-associated pulmonary hypertension: a role for endothelin receptor antagonists?
    Georgia G Pitsiou
    Respiratory Failure Unit, G Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
    Ther Adv Respir Dis 3:99-101. 2009
  8. doi request reprint Monitoring changes in quality of life in patients with lung cancer by using specialised questionnaires: implications for clinical practice
    Hellie Lithoxopoulou
    Pulmonary Department Oncology Unit, G Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, 57010, Greece
    Support Care Cancer 22:2177-83. 2014
  9. doi request reprint Lemierre's syndrome presenting to the ED: rapidly fatal sepsis caused by methicillin-susceptible Staphylococcus aureus Staphylococcus protein A type t044
    Georgia Pitsiou
    Respiratory Failure Unit, Aristotle University of Thessaloniki, G H G Papanikolaou, Exohi, Thessaloniki, 57010, Greece
    Am J Emerg Med 31:268.e5-7. 2013

Collaborators

  • Lonny Yarmus
  • Anna Papa
  • Joseph L Kuti
  • Georgia G Pitsiou
  • Paschalina Kontou
  • Kalliopi Chatzika
  • Paul Zarogoulidis
  • Konstantinos Zarogoulidis
  • Konstantinos Porpodis
  • Haidong Huang
  • Hellie Lithoxopoulou
  • Katerina Manika
  • Athanasia Pataka
  • Sofia Lampaki
  • Dionysios Spyratos
  • Despina Papakosta
  • Wolfgang Hohenforst-Schmidt
  • Qiang Li
  • Nikolaos Pezirkianidis
  • John Organtzis
  • Ellada Eleftheriadou
  • Dimitris Petridis
  • Theodora Tsiouda
  • Sevasti Bostantzopoulou
  • Theodore Kontakiotis
  • Maria Papaioannou
  • Maria Sionidou
  • Ioannis Stanopoulos
  • Paraskevi Argyropoulou-Pataka
  • David P Nicolau

Detail Information

Publications9

  1. doi request reprint Validation of the Infectious Diseases Society of America/American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniae
    Paschalina Kontou
    Division of Pulmonary Critical Care, G Papanikolaou Hospital, Thessaloniki, Greece
    Am J Emerg Med 27:968-74. 2009
    ..In this study, the 2007 Infectious Diseases Society of America/American Thoracic Society (IDSA/ATS) consensus criteria for ICU admission were compared with other severity scores in predicting ICU admission and mortality...
  2. pmc Pharmacokinetics of ciprofloxacin and its penetration into bronchial secretions of mechanically ventilated patients with chronic obstructive pulmonary disease
    Paschalina Kontou
    A Intensive Care Unit, G Papanikolaou Hospital, Exohi, Thessaloniki 57010, Greece
    Antimicrob Agents Chemother 55:4149-53. 2011
    ..There is wide interindividual variability in its pharmacokinetic parameters in critically ill COPD patients and inadequate pharmacodynamic exposure against bacteria with MICs of ≥0.5 μg/ml...
  3. pmc Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment
    Georgia Pitsiou
    Pulmonary Department, G Papanikolaou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
    Drug Des Devel Ther 8:1753-63. 2014
    ..12 μm, respectively). Erlotinib and imatinib can be administered as an aerosols, and further in vivo experimentation is necessary to investigate the positive effects of these drugs in the treatment of pulmonary hypertension. ..
  4. pmc Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol
    Paul Zarogoulidis
    Pulmonary Department Oncology Unit, G Papanikolaou General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
    Drug Des Devel Ther 8:1065-72. 2014
    ..At this time, several antibiotics have been investigated as possibilities for aerosol administration, but local therapy has been found to be more efficient in several diseases...
  5. doi request reprint Pharmacokinetics of moxifloxacin and high-dose levofloxacin in severe lower respiratory tract infections
    Paschalina Kontou
    A Intensive Care Unit, G Papanikolaou Hospital, Thessaloniki, Greece
    Int J Antimicrob Agents 42:262-7. 2013
    ..They ensure optimal pharmacodynamic exposure against the majority of microbes involved in these infections. However, the predicted efficacy against Gram-negative bacteria with MICs ≥ 0.5 mg/L appears to be low...
  6. pmc Moxifloxacin pharmacokinetics and pleural fluid penetration in patients with pleural effusion
    Kalliopi Chatzika
    Respiratory Infections Unit, Pulmonary Department, Aristotle University of Thessaloniki, G Papanikolaou Hospital, Thessaloniki, Greece
    Antimicrob Agents Chemother 58:1315-9. 2014
    ..However, in both groups, the degree of MXF PF penetration and the on-site drug exposure, expressed by AUC24PF, did not differ according to the type of pleural effusion...
  7. doi request reprint Sarcoidosis-associated pulmonary hypertension: a role for endothelin receptor antagonists?
    Georgia G Pitsiou
    Respiratory Failure Unit, G Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
    Ther Adv Respir Dis 3:99-101. 2009
    ..Addition of bosentan, a dual endothelin receptor antagonist, resulted in marked improvement in functional class and exercise capacity of the patient, allowing gradual tapering of steroids...
  8. doi request reprint Monitoring changes in quality of life in patients with lung cancer by using specialised questionnaires: implications for clinical practice
    Hellie Lithoxopoulou
    Pulmonary Department Oncology Unit, G Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, 57010, Greece
    Support Care Cancer 22:2177-83. 2014
    ..Quality of life (QoL) in lung cancer patients is overlooked due to the severity of the disease. Changes in factors comprising QoL need further exploration to determine therapy targets...
  9. doi request reprint Lemierre's syndrome presenting to the ED: rapidly fatal sepsis caused by methicillin-susceptible Staphylococcus aureus Staphylococcus protein A type t044
    Georgia Pitsiou
    Respiratory Failure Unit, Aristotle University of Thessaloniki, G H G Papanikolaou, Exohi, Thessaloniki, 57010, Greece
    Am J Emerg Med 31:268.e5-7. 2013
    ..Recognition of such virulent community-acquired strains is of great importance because they could prove to be emerging pathogens for life-threatening diseases...